| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.079 | 0.06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |